What Happened?
Palo Alto, CA-based Kodiak-Sciences Appointed Victor Perlroth as Chief Executive Officer
About the Company
Kodiak is the leading provider of standards-based Push-to-Talk (PTT) to wireless carriers and operators as a Software-as-a-Service solution. Kodiak`s PTT platform delivers clear, reliable, sub-second calling performance with LMR interoperability over 4G LTE, WiFi, and 3G networks. The Kodiak solution allows organizations to cost-effectively scale their LMR networks, add users, extend coverage, and access broadband GPS capabilities. The Kodiak-powered platform supports a robust partner ecosystem including iOS, Android handsets/tablets, ruggedized devices, accessories, and enterprise productivity applications -all available from leading global carriers including AT&T, Telefonica, and Verizon.
About the Person
Victor Perlroth co-founded Kodiak Sciences in 2009 and is the company`s Chairman and Chief Executive Officer. Together with a talented core team, he has built Kodiak on a foundation of scientific excellence with a simple mission—to design and develop novel medicines for highly prevalent diseases. Under Dr. Perlroth`s leadership, Kodiak is building a pipeline of potentially life transforming ophthalmology drug candidates. Previously, Dr. Perlroth served as Venture Partner and then Entrepreneur in Residence at MPM Capital, a dedicated healthcare venture capital investment firm. In 2003, Dr. Perlroth co-founded Avidia, a biopharmaceuticals drug discovery and development company where he served as General Manager and Vice President of Corporate Development. In this role, at various times he had broad management responsibility across both corporate and research and development activities. Dr. Perlroth was one of two principals involved in the acquisition of the company by Amgen for $450 million. Earlier, Dr. Perlroth worked at Guzik Technical Enterprises, the industry-leading provider of test equipment to the hard disk drive industry, where he was Chief Operating Officer. Dr. Perlroth earned his M.D. and M.B.A. degrees from Stanford University and an A.B. in Molecular Biology summa cum laude from Princeton University.
Info Source
Press Release
Short Profile